What is the recommended treatment for uncomplicated urogenital Chlamydia trachomatis infection in adults, including both non‑pregnant and pregnant patients?

Treatment of Uncomplicated Urogenital Chlamydia Trachomatis

For non-pregnant adults with uncomplicated urogenital chlamydia, treat with doxycycline 100 mg orally twice daily for 7 days as first-line therapy; azithromycin 1 g orally as a single dose is an equally effective alternative when adherence to a 7-day regimen is uncertain. 1

First-Line Treatment for Non-Pregnant Adults

Both doxycycline and azithromycin achieve microbial cure rates of 97–98% in clinical trials and are recommended as co-first-line options by the CDC. 1

Doxycycline 100 mg orally twice daily for 7 days should be your default choice because: 1

• It has extensive safety data and a longer track record 1
• It is substantially less costly than azithromycin 1
• It may be more effective for rectal chlamydial infection (≈100% cure vs ≈79% with azithromycin) 1
• It retains effectiveness even when real-world adherence is imperfect 1
• In men specifically, azithromycin shows higher microbiological failure rates compared to doxycycline (RR 2.45,95% CI 1.36 to 4.41) 2

Azithromycin 1 g orally as a single dose should be selected when: 1

• Adherence to a 7-day regimen is uncertain 3, 1
• Directly observed therapy is required 1
• Patients have erratic health-care-seeking behavior 1
• The convenience of single-dose therapy outweighs the slightly higher cost 4

A once-daily doxycycline formulation (doxycycline hyclate delayed-release 200 mg tablet, brand name Doryx) for 7 days is also FDA-approved and demonstrates comparable efficacy to twice-daily dosing with potentially better tolerability (less nausea and vomiting). 3

Alternative Regimens (When First-Line Options Are Unsuitable)

Use these only when both doxycycline and azithromycin are contraindicated or not tolerated: 3

• Erythromycin base 500 mg orally four times daily for 7 days 3, 1
• Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days 3, 1
• Ofloxacin 300 mg orally twice daily for 7 days 3, 1
• Levofloxacin 500 mg orally once daily for 7 days 1

Important caveats: Erythromycin regimens are less efficacious than doxycycline or azithromycin and cause frequent gastrointestinal side effects that reduce compliance. 1 The quinolones (ofloxacin, levofloxacin) offer no dosage advantage and are more expensive. 1

Treatment During Pregnancy

Doxycycline and all quinolones are absolutely contraindicated in pregnancy. 3, 1

First-line for pregnant patients: 3, 1

• Erythromycin base 500 mg orally four times daily for 7 days

Alternative regimens if erythromycin is not tolerated: 3, 1

• Erythromycin base 250 mg orally four times daily for 14 days
• Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days
• Erythromycin ethylsuccinate 400 mg orally four times daily for 14 days
• Amoxicillin 500 mg orally three times daily for 7–10 days 3, 1

Critical warning: Erythromycin estolate is contraindicated in pregnancy because it causes drug-related hepatotoxicity. 3, 1

Regarding azithromycin in pregnancy: Although preliminary data suggest azithromycin may be safe and effective, the 1998 CDC guidelines state that data are insufficient to recommend routine use in pregnant women. 3 However, increasing numbers of obstetricians in the United States are using azithromycin to treat pregnant women because of its fewer side effects and improved adherence. 4

Mandatory follow-up for pregnant patients: Repeat testing (preferably by culture) 3 weeks after completion of therapy is recommended because none of the pregnancy-safe regimens are highly efficacious and erythromycin's frequent side effects discourage compliance. 3

Special Populations

HIV-infected patients receive identical treatment regimens as HIV-negative individuals—there is no need to modify therapy based on HIV status. 3, 1

Patients with doxycycline allergy should receive azithromycin 1 g as a single dose; if both are unsuitable, use one of the alternative regimens listed above. 1

Adolescents ≤17 years of age: Do not use ofloxacin or other quinolones in this population. 3

Follow-Up and Test of Cure

Routine test-of-cure is NOT recommended for non-pregnant patients treated with doxycycline or azithromycin unless: 3, 1

• Persistent symptoms are present
• Reinfection is suspected
• Compliance is questionable

When test-of-cure is performed: Specimens must be collected ≥3 weeks after completion of therapy to avoid false-positive NAAT results from detection of non-viable organisms. 3, 1

Reinfection screening: All women should be retested approximately 3 months after treatment to detect reinfection, which is common (39% in one adolescent cohort) and increases the risk of pelvic inflammatory disease. 3, 1 Some studies demonstrate high reinfection rates in women several months post-treatment, making rescreening particularly important in adolescents. 3

Partner Management

All sexual partners must be evaluated and treated. 3, 1

Specific partner tracing intervals: 3, 1

• Treat partners exposed within 60 days before the index patient's diagnosis
• For symptomatic patients, treat partners exposed within 30 days of symptom onset
• Always treat the most recent partner even if contact occurred outside these intervals

Sexual abstinence requirements: 3, 1

• Patients must abstain from sexual intercourse for 7 days after single-dose azithromycin OR until completion of the 7-day doxycycline course
• Abstinence must continue until all sex partners have completed treatment to prevent reinfection

Timely partner treatment is essential for decreasing reinfection risk in the index patient. 3

Critical Pitfalls to Avoid

Do not perform test-of-cure <3 weeks after treatment because NAATs detect nucleic acids from dead organisms, yielding false-positive results. 3, 1

Do not use quinolones in pregnancy or adolescents ≤17 years. 3, 1

Do not assume adherence to 7-day regimens in high-risk populations (adolescents, patients with erratic healthcare-seeking behavior); consider directly observed single-dose azithromycin instead. 1

When treating gonorrhea, presumptively treat for chlamydia due to high coinfection rates. 1

Ensure partner treatment is completed—untreated partners are the major source of reinfection and treatment failure. 3, 1, 5

Do not use erythromycin estolate in pregnancy due to hepatotoxicity risk. 3, 1